Victoria Hospital
London, Ontario, N6A 5W9, Canada
NCT Number: NCT04099121
Symptoms of female pelvic floor dysfunction, such as incontinence and pelvic organ prolapse, can be alleviated by using pessaries, which are passive medical devices that are inserted in the vagina to support the pelvic organs. Currently, pessaries are fit through trial and error after manual examination, the accuracy of which depends on the physician's expertise level.
The objective of this study is to evaluate the feasibility of using 3D translabial ultrasound imaging of the vagina at various distension volumes to predict the pessary size for successful fit. Ultrasound images will be obtained using commercially available 3D ultrasound probes (Philips, Netherlands), as well as a commercially available 2D ultrasound probe (Philips, Netherlands), which is linearly scanned to capture a 3D volume. The linear scanning will be performed by attaching the 2D probe to a motorized hand-held scanner, which is used to tilt and move the probe to acquire images. Please note that the hand-held scanner does not come in contact with the patient. To distend the vagina, a sterile bag is inserted in the vagina and gradually filled with water using a commercially available urodynamic system (Laborie, Canada) until the vaginal capacity is reached, without causing any discomfort to the patient. This image acquisition technique, previously reported in the literature, is referred to as 3D ultrasound vaginal manometry in this study.
To achieve the objective of this project, 35 pelvic organ prolapse patients, who (i) are current pessary users, (ii) can perform self-care of the pessary, and (iii) can provide informed consent, will be invited to participate in the study. Patients will be asked to remove their pessary prior to ultrasound imaging. Then, 3D ultrasound vaginal manometry will be performed, using the technique described above. Ultrasound images will be analyzed once data acquisition is completed. The size of the pessary estimated from ultrasound images will be compared with the actual pessary size used by the patient.
Looking for future studies?
Notify MeFemale
Interventional
Not applicable
London, Ontario, N6A 5W9, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3D ultrasound of the pelvic floor and vaginal cavity will be obtained by using a commercial ultrasound system.
Time frame: Up to 3 months following data collection
The predicted pessary size in cubic mm will be compared with the actual size of the pessary used by the patient
Time frame: Up to 3 months following data collection
The predicted pessary shape will be compared with the actual shape of the pessary used by the patient by calculating the DICE coefficient.
Western University, Canada
Other
Evaluation of 3D Ultrasound Vaginal Manometry for Estimating the Optimal Pessary Size for Patients With Pelvic Organ Prolapse
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06520722
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cairo, Egypt
View Trial DetailsNCT04440475
Anesthesia, Local, Female Urogenital Diseases
Toledo, Ohio, United States
View Trial DetailsNCT04523298
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Leuven, Belgium
View Trial DetailsNCT03307824
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Bron, France
View Trial Details